MANEGMENT OF PAIN IN NEONATES, INFANTS AND SMALL CHILDREN

Abstract

Effective pain management in neonates, infants, and young children is a critical clinical and ethical imperative. The immature yet functional nociceptive system in this population, characterized by underdeveloped inhibitory pathways and a tendency for wind-up hyperexcitability, means they experience pain intensely and are vulnerable to its detrimental short-term physiological effects and potential long-term neurodevelopmental sequelae. This review underscores the role of frequent, objective pain assessment using validated, age-appropriate tools to guide therapy. It advocates for a proactive, multimodal approach that integrates non-pharmacological interventions—such as sucrose, breastfeeding, skin-to-skin contact, and distraction—as first-line strategies. For more significant pain, a tailored pharmacological strategy is essential. This involves a stepped approach utilizing non-opioid analgesics (e.g., paracetamol, NSAIDs, metamizole), judicious opioid administration, and adjuncts like ketamine and dexmedetomidine. The paper highlights the importance of locoregional anesthetic techniques (e.g., caudal, epidural, and peripheral nerve blocks) in providing superior intraoperative and postoperative analgesia while minimizing systemic drug exposure. Dosing must account for profound age-related pharmacokinetic and pharmacodynamic differences. Ultimately, successful pediatric pain management requires a paradigm shift towards preemptive and multimodal analgesia, meticulous assessment, and interdisciplinary collaboration to ensure patient safety, alleviate suffering, and improve outcomes.